Lundbeck develops pharmaceuticals for treating diseases of the central nervous system including depression, schizophrenia, Alzheimers, Parkinson's and sleep disorders. It is a research-based company.
Registrars: |
Address: | |
Phone: | |
Fax: | |
Website: | |
Email: |
ISIN: | DK0010287234 |